Ocular Manifestations of Inflammatory Bowel Disease
NCT04771039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2021-02-25
Summary
Ocular damage is found in the 3rd rank of extra intestinal manifestations (MEI) Potentially serious functional complications (see uveitis and risk of blindness) requiring rapid management Rare uveitis in the literature (0.5% -3%), study on a large sample to assess their prevalence in patients with IBD at the Nancy CHRU and describe all the ocular manifestations that can be found.
Conditions
- Inflammatory Bowel Diseases
- Ophthalmopathy
Interventions
- OTHER
-
reason for consultation
search in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2020-12-01
- Completion
- 2020-12-12
More Related Trials
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704 ·Status: UNKNOWN ·Phase: NA
-
Comparing the Accuracy of Different Ultrasound-based Scores to Assess Disease Severity in Patients with Inflammatory Bowel Disease
NCT06705972 ·Status: NOT_YET_RECRUITING
-
Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases
NCT03841045 ·Status: UNKNOWN
-
Prevalence of Encephalopathy in Patients With Inflammatory Bowel Diseases
NCT05519904 ·Status: UNKNOWN
-
Progression of Damage in Ulcerative Colitis
NCT03955328 ·Status: UNKNOWN ·Phase: NA
-
Inflammatory Bowel Disease Research Registry
NCT00574028 ·Status: COMPLETED
-
Bowel Urgency in Inflammatory Bowel Disease
NCT06069167 ·Status: COMPLETED
-
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
NCT02330458 ·Status: UNKNOWN
-
Inflammatory Bowel Disease (IBD) and Covid-19 Infection
NCT04492267 ·Status: UNKNOWN
-
Inflammatory Bowel Diseases Remission Registry
NCT04912999 ·Status: RECRUITING
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases
NCT03615287 ·Status: UNKNOWN
-
Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
NCT07343726 ·Status: NOT_YET_RECRUITING
-
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
NCT06015789 ·Status: COMPLETED
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Lymphoma in IBD
NCT00577538 ·Status: COMPLETED
-
Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
NCT06721767 ·Status: RECRUITING
-
Contrast-enhanced Bowel Ultrasound in Making a Diagnosis and Follow-up of Patients With Inflammatory Bowel Disease
NCT03744130 ·Status: UNKNOWN ·Phase: NA
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
NCT06655415 ·Status: RECRUITING
-
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
NCT06551194 ·Status: RECRUITING
-
Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD)
NCT01524120 ·Status: WITHDRAWN
-
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
NCT06299631 ·Status: COMPLETED
-
Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain
NCT03689257 ·Status: COMPLETED